Timothy Sullivan
2017
In 2017, Timothy Sullivan earned a total compensation of $2.3M as Chief Financial Officer at Apellis Pharmaceuticals.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $2,187,760 |
| Salary | $68,939 |
| Total | $2,296,699 |
Sullivan received $2.2M in option awards, accounting for 95% of the total pay in 2017.
Sullivan also received $40K in bonus and $68.9K in salary.
Rankings
In 2017, Timothy Sullivan's compensation ranked 4,834th out of 14,666 executives tracked by ExecPay. In other words, Sullivan earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,834 out of 14,666 | 67th |
Division Manufacturing | 1,725 out of 5,772 | 70th |
Major group Chemicals And Allied Products | 514 out of 2,075 | 75th |
Industry group Drugs | 397 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 316 out of 1,333 | 76th |
Source: SEC filing on April 25, 2018.
Sullivan's colleagues
We found two more compensation records of executives who worked with Timothy Sullivan at Apellis Pharmaceuticals in 2017.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019